159 related articles for article (PubMed ID: 32424610)
1. Assessing CT imaging features combined with CEA and CA125 levels to identify endometriosis-associated ovarian cancer.
Li M; Tan J; Zhang Y; Ai C; Wang H; Zhang H; Jin Y; Chen Y
Abdom Radiol (NY); 2021 Jun; 46(6):2367-2375. PubMed ID: 32424610
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary.
Morioka S; Kawaguchi R; Yamada Y; Iwai K; Yoshimoto C; Kobayashi H
J Ovarian Res; 2019 Feb; 12(1):20. PubMed ID: 30803452
[TBL] [Abstract][Full Text] [Related]
3. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
[TBL] [Abstract][Full Text] [Related]
4. Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma.
Shinmura H; Yoneyama K; Harigane E; Tsunoda Y; Fukami T; Matsushima T; Takeshita T
Int J Gynecol Cancer; 2020 Jun; 30(6):831-836. PubMed ID: 32354795
[TBL] [Abstract][Full Text] [Related]
5. Preoperative discrimination of tumour stage in clear cell carcinoma of the ovary using computed tomography and magnetic resonance imaging.
Joo HL; Shin YR; Rha SE; Park CS; Shim DJ; Kim K
Eur J Radiol; 2018 Dec; 109():19-26. PubMed ID: 30527303
[TBL] [Abstract][Full Text] [Related]
6. Factors that Differentiate between Endometriosis-associated Ovarian Cancer and Benign Ovarian Endometriosis with Mural Nodules.
Tanase Y; Kawaguchi R; Takahama J; Kobayashi H
Magn Reson Med Sci; 2018 Jul; 17(3):231-237. PubMed ID: 28824051
[TBL] [Abstract][Full Text] [Related]
7. Differentiation between ovarian metastasis from colorectal carcinoma and primary ovarian carcinoma: Evaluation of tumour markers and "mille-feuille sign" on computed tomography/magnetic resonance imaging.
Kurokawa R; Nakai Y; Gonoi W; Mori H; Tsuruga T; Makise N; Ushiku T; Abe O
Eur J Radiol; 2020 Mar; 124():108823. PubMed ID: 31935596
[TBL] [Abstract][Full Text] [Related]
8. The presence of clear cell glands around the ovarian endometrioid cyst has an association with clear cell carcinoma.
Qu J; Yu J; Zhong S; Wang W; Wang Q; Du B
Virchows Arch; 2023 Jun; 482(6):1021-1034. PubMed ID: 36580137
[TBL] [Abstract][Full Text] [Related]
9. Whole-tumor ADC histogram analysis for differentiating endometriosis-related tumors: seromucinous borderline tumor, clear cell carcinoma and endometrioid carcinoma.
Lu J; Zhao S; Ma F; Li H; Li Y; Qiang J
Abdom Radiol (NY); 2023 Feb; 48(2):724-732. PubMed ID: 36401131
[TBL] [Abstract][Full Text] [Related]
10. Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.
Miyagi E; Arakawa N; Sakamaki K; Yokota NR; Yamanaka T; Yamada Y; Yamaguchi S; Nagao S; Hirashima Y; Kasamatsu Y; Kato H; Mogami T; Miyagi Y; Kobayashi H
Int J Clin Oncol; 2021 Jul; 26(7):1336-1344. PubMed ID: 34009487
[TBL] [Abstract][Full Text] [Related]
11. Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age.
Kondalsamy-Chennakesavan S; Hackethal A; Bowtell D; ; Obermair A
Gynecol Oncol; 2013 Jun; 129(3):467-71. PubMed ID: 23500084
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging for distinguishing ovarian clear cell carcinoma from high-grade serous carcinoma.
Ma FH; Qiang JW; Zhang GF; Li HM; Cai SQ; Rao YM
J Ovarian Res; 2016 Jul; 9(1):40. PubMed ID: 27377917
[TBL] [Abstract][Full Text] [Related]
13. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers in serum and ascites in the diagnosis of benign and malignant ascites.
Zhu FL; Ling AS; Wei Q; Ma J; Lu G
Asian Pac J Cancer Prev; 2015; 16(2):719-22. PubMed ID: 25684514
[TBL] [Abstract][Full Text] [Related]
15. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
[TBL] [Abstract][Full Text] [Related]
16. Combination of Sonographic Morphology Score and Tumor Markers for Detecting Postoperative Recurrent Pelvic Ovarian Carcinoma: Compared With MRI Assessment.
Shen ZY; Shen AJ; Yang SL; Wu MF
Ultrasound Q; 2019 Mar; 35(1):45-53. PubMed ID: 30672869
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
[TBL] [Abstract][Full Text] [Related]
18. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
[TBL] [Abstract][Full Text] [Related]
19. The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas?
McMullan JC; Graham MJ; Craig EF; McCluggage WG; Hunter DH; Feeney L
Eur J Surg Oncol; 2024 Mar; 50(6):108247. PubMed ID: 38522332
[TBL] [Abstract][Full Text] [Related]
20. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]